Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BILCAP adjuvant capecitabine trial after resection of biliary tract cancer
ISRCTN72785446Phase 3Completed
- Sponsor
- University of Southampton
- Start
- Jul 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in biliary cancer comparing Capecitabine with Observation (2 arms). Primary endpoint: 2-year survival. Started Jul 2006; status: completed.
02
Drugs
capecitabine
03
Conditions
biliary cancer
Beyond the preview
Go deeper on ISRCTN72785446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN72785446.